Clinical Trial Update: Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating allogeneic mesenchymal stem cells for bone defects and nonunion fractures, sponsored by Indonesia University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metaphyseal Fibrous Defect
• Nonunion Fracture

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Indonesia University | Conditions: Non Union Fracture, Metaphyseal Fibrous Defect | EARLY_Phase 1 | Status: UNKNOWN